p.73 抽出テキスト

CLINICAL STATEMENTS AND GUIDELINES

Circulation. 2024;149:e1313–e1410. DOI: 10.1161/CIR.0000000000001251 June 11, 2024 e1385

5 Parvar SL, Thiyagarajah A, Nerlekar N, et al. A systematic review and meta-

analysis of gender differences in long-term mortality and cardiovascular events in peripheral artery disease. J Vasc Surg. 2021;73:1456–1465.e7. 6.	 Lefebvre KM, Chevan J. The persistence of gender and racial disparities in vascular lower extremity amputation: an examination of HCUP-NIS data (2002-2011). Vasc Med. 2015;20:51–59. 7.	 Lo RC, Bensley RP, Dahlberg SE, et al. Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease. J Vasc Surg. 2014;59:409–418.e3. 8.	 Scierka LE, Jelani QU, Smolderen KG, et al. Patient representativeness of a peripheral artery disease cohort in a randomized control trial versus a realworld cohort: the CLEVER trial versus the PORTRAIT registry. Contemp Clin Trials. 2022;112:106624. 9.	 Jin X, Chandramouli C, Allocco B, et al. Women's participation in cardiovascular clinical trials from 2010 to 2017. Circulation. 2020;141:540–548. 10.	 Michos ED, Reddy TK, Gulati M, et al. Improving the enrollment of women

and racially/ethnically diverse populations in cardiovascular clinical trials: an ASPC practice statement. Am J Prev Cardiol. 2021;8:100250. 4.2.3. Geography and Socioeconomic Status 1.	 Minc SD, Hendricks B, Misra R, et al. Geographic variation in amputation rates among patients with diabetes and/or peripheral arterial disease in the rural state of West Virginia identifies areas for improved care. J Vasc Surg. 2020;71:1708–1717.e5. 2.	 Minc SD, Goodney PP, Misra R, et al. The effect of rurality on the risk of primary amputation is amplified by race. J Vasc Surg. 2020;72:1011– 1017. 3.	 Cross SH, Mehra MR, Bhatt DL, et al. Rural-urban differences in cardiovascular mortality in the US, 1999-2017. JAMA. 2020;323:1852–1854. 4.	 Hurst JE, Tehan PE, Hussey K, et al. Association of peripheral artery disease and chronic limb-threatening ischemia with socioeconomic deprivation in people with diabetes: a population data-linkage and geospatial analysis. Vasc Med. 2021;26:147–154. 5.	 Parker MA, Weinberger AH, Eggers EM, et al. Trends in Rural and urban cigarette smoking quit ratios in the US from 2010 to 2020. JAMA Netw Open. 2022;5:e2225326. 6.	 Harris JK, Beatty K, Leider JP, et al. The double disparity facing rural local health departments. Annu Rev Public Health. 2016;37:167–184. 7.	 Peacock JM, Keo HH, Duval S, et al. The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008. Prev Chronic Dis. 2011;8:A141. 8.	 Fanaroff AC, Yang L, Nathan AS, et al. Geographic and socioeconomic disparities in major lower extremity amputation rates in metropolitan areas. J Am Heart Assoc. 2021;10:e021456. 9.	 Economic Innovation Group. Distressed communities [website]. Updated

2023. Accessed February 2, 2023. https://eig.org/distressed-communities/. 4.3. Considerations in Management of PAD in Older Patients 1.	Arya S, Khakharia A, Rothenberg KA, et al. Association of peripheral artery disease with life-space mobility restriction and mortality in community-dwelling older adults. J Vasc Surg. 2020;71:2098–2106.e1. 2.	 Mallon T, Eisele M, Konig HH, et al. Lifestyle aspects as a predictor of pain among oldest-old primary care patients-a longitudinal cohort study. Clin Interv Aging. 2019;14:1881–1888. 3.	 Matsushita K, Ballew SH, Sang Y, et al. Ankle-brachial index and physical function in older individuals: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2017;257:208–215. 4.	 Mii S, Guntani A, Kawakubo E, et al. Preoperative nutritional status is an independent predictor of the long-term outcome in patients undergoing open bypass for critical limb ischemia. Ann Vasc Surg. 2020;64:202–212. 5.	 Salomon du Mont L, Leclerc B, Morgant MC, et al. Impact of nutritional state on critical limb ischemia early outcomes (DENUCRITICC study). Ann Vasc Surg. 2017;45:10–15. 6.	 Matsuo Y, Kumakura H, Kanai H, et al. The geriatric nutritional risk index predicts long-term survival and cardiovascular or limb events in peripheral arterial disease. J Atheroscler Thromb. 2020;27:134–143. 7.	 Sugai T, Watanabe T, Otaki Y, et al. Decreased psoas muscle computed tomography value predicts poor outcome in peripheral artery disease. Circ J. 2018;82:3069–3075. 8.	 Vedder IR, Levolger S, Dierckx R, et al. Effect of muscle depletion on survival

in peripheral arterial occlusive disease: quality over quantity. J Vasc Surg. 2020;72:2006–2016. e2001. 9 Pereira-Neves A, Barros D, Rocha-Neves J, et al. Impact of sarcopenia in

aortoiliac occlusive disease in Mediterranean population. Turk Gogus Kalp Damar Cerrahisi Derg. 2020;28:615–622. 10.	 Rothenberg KA, George EL, Trickey AW, et al. Assessment of the risk analysis index for prediction of mortality, major complications, and length of stay in patients who underwent vascular surgery. Ann Vasc Surg. 2020;66:442– 453. 11.	 Takeji Y, Yamaji K, Tomoi Y, et al. Impact of frailty on clinical outcomes in patients with critical limb ischemia. Circ Cardiovasc Interv. 2018;11:e006778. 12.	 Schaller MS, Ramirez JL, Gasper WJ, et al. Frailty is associated with an increased risk of major adverse cardiac events in patients with stable claudication. Ann Vasc Surg. 2018;50:38–45. 13.	 Yokoyama M, Watanabe T, Otaki Y, et al. Impact of objective malnutrition status on the clinical outcomes in patients with peripheral artery disease following endovascular therapy. Circ J. 2018;82:847–856. 14.	 Erben Y, Mena-Hurtado CI, Miller SM, et al. Increased mortality in octogenarians treated for lifestyle limiting claudication. Catheter Cardiovasc Interv. 2018;91:1331–1338. 15.	 Hamdi A, Al-Zubeidy B, Obirieze A, et al. Lower extremity arterial reconstruction in octogenarians and older. Ann Vasc Surg. 2016;34:171–177. 16.	 Song P, Rudan D, Zhu Y, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7:e1020–e1030. 17.	 Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/ PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126:e354–e471. 18.	 Schwartz JB, Schmader KE, Hanlon JT, et al. Pharmacotherapy in older adults with cardiovascular disease: report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop. J Am Geriatr Soc. 2019;67:371–380. 19.	 Kantor ED, Rehm CD, Haas JS, et al. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA. 2015;314:1818– 1831. 20.	 Dinga Madou I, Slade MD, Orion KC, et al. The impact of functional status on the outcomes of endovascular lower extremity revascularization for critical limb ischemia in the elderly. Ann Vasc Surg. 2017;45:42–48. 21.	 Altin SE, Castro-Dominguez YS, Kennedy KF, et al. Predictors of underutilization of medical therapy in patients undergoing endovascular revascularization for peripheral artery disease. J Am Coll Cardiol Intv. 2020;13:2911–2918. 22.	 Addison O, Prior SJ, Kundi R, et al. Sarcopenia in peripheral arterial disease: prevalence and effect on functional status. Arch Phys Med Rehabil. 2018;99:623–628. 23.	 Ma KF, Berends B, Vedder IR, et al. Quantification of muscle mass in the legs of patients with peripheral arterial occlusive disease: associations between volumetric and cross-sectional single-slice measurements for identification of atrophy and focal sarcopenia. J Cardiovasc Surg (Torino). 2019;60:672–678. 24.	 Peters CML, de Vries J, Lodder P, et al. Is a good quality of life and health status possible in older patients dying from critical limb-threatening ischemia: a prospective clinical study. Ann Vasc Surg. 2020;64:198–201. 25.	 Klaphake S, de Leur K, Mulder PG, et al. Mortality after major amputation in elderly patients with critical limb ischemia. Clin Interv Aging. 2017;12:1985– 1992. 26.	 Barshes NR, Menard MT, Nguyen LL, et al. Infrainguinal bypass is associated with lower perioperative mortality than major amputation in high-risk surgical candidates. J Vasc Surg. 2011;53:1251–1259.e1. 27.	 Peters CML, de Vries J, Lodder P, et al. Quality of life and not health status

improves after major amputation in the elderly critical limb ischaemia patient. Eur J Vasc Endovasc Surg. 2019;57:547–553. 5.1. Antiplatelet and Antithrombotic Therapy for PAD 1.	 Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86. 2.	 Critical Leg Ischaemia Prevention Study (CLIPS) Group, Catalano M, Born

G. Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial. J Intern Med. 2007;261:276–284.

Downloaded from http://ahajournals.org by on October 7, 2026